Report Detail

Pharma & Healthcare Cerus Corp (CERS) - Financial and Strategic SWOT Analysis Review

  • RnM3611936
  • |
  • 22 July, 2019
  • |
  • Global
  • |
  • 54 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Cerus Corp (CERS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes Intercept Blood System, which reduces the risk of transfusion-transmitted infections by inactivating a wide range of pathogens including viruses, bacteria and parasites present in donated blood. The product is for use with three blood components,: platelets, plasma and red blood cells. Cerus’ Intercept blood system is marketed and sold in several countries worldwide including the US, Belgium, Kuwait, France, Spain, Portugal, Switzerland, Commonwealth of Independent States (CIS) countries and other countries. Cerus is headquartered in Concord, California, the US.

Cerus Corp Key Recent Developments

Jun 03,2019: Cerus announces new corporate brand and global headquarters
May 07,2019: Cerus announces record first quarter 2019 results
Mar 05,2019: Cerus names Jami Nachtsheim as Board Director
Feb 26,2019: Cerus announces record fourth quarter and full year 2018 results
Jan 07,2019: Cerus announces preliminary fourth quarter and full year 2018 product revenue

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents

    Table of Contents

      List of Tables

        List of Figures

          Section 1 - About the Company

            Cerus Corp - Key Facts

              Cerus Corp - Key Employees

                Cerus Corp - Key Employee Biographies

                  Cerus Corp - Major Products and Services

                    Cerus Corp - History

                      Cerus Corp - Company Statement

                        Cerus Corp - Locations And Subsidiaries

                          Head Office

                            Other Locations & Subsidiaries

                              Section 2 – Company Analysis

                                Company Overview

                                  Cerus Corp - Business Description

                                    Cerus Corp - SWOT Analysis

                                      SWOT Analysis - Overview

                                        Cerus Corp - Strengths

                                          Cerus Corp - Weaknesses

                                            Cerus Corp - Opportunities

                                              Cerus Corp - Threats

                                                Cerus Corp - Key Competitors

                                                  Section 3 – Company Financial Ratios

                                                    Financial Ratios - Capital Market Ratios

                                                      Financial Ratios - Annual Ratios

                                                        Performance Chart

                                                          Financial Performance

                                                            Financial Ratios - Interim Ratios

                                                              Financial Ratios - Ratio Charts

                                                                Section 4 – Company’s Lifesciences Financial Deals and Alliances

                                                                  Cerus Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

                                                                    Cerus Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

                                                                      Cerus Corp, Recent Deals Summary

                                                                        Section 5 – Company’s Recent Developments

                                                                          Jun 03, 2019: Cerus announces new corporate brand and global headquarters

                                                                            May 07, 2019: Cerus announces record first quarter 2019 results

                                                                              Mar 05, 2019: Cerus names Jami Nachtsheim as Board Director

                                                                                Feb 26, 2019: Cerus announces record fourth quarter and full year 2018 results

                                                                                  Jan 07, 2019: Cerus announces preliminary fourth quarter and full year 2018 product revenue

                                                                                    Jan 04, 2019: William Moore appointed as Cerus Senior Vice President of manufacturing operations and supply chain

                                                                                      Nov 01, 2018: Cerus reports third quarter 2018 results

                                                                                        Oct 09, 2018: Cerus appoints Eric Bjerkholt to board of directors

                                                                                          Aug 02, 2018: Cerus announces second quarter 2018 financial results

                                                                                            May 08, 2018: Cerus Reports First Quarter 2018 Results

                                                                                              Section 6 – Appendix

                                                                                                Methodology

                                                                                                  Ratio Definitions

                                                                                                    About GlobalData

                                                                                                      Contact Us

                                                                                                        Disclaimer

                                                                                                        Summary:
                                                                                                        Get latest Market Research Reports on Cerus Corp (CERS). Industry analysis & Market Report on Cerus Corp (CERS) is a syndicated market report, published as Cerus Corp (CERS) - Financial and Strategic SWOT Analysis Review. It is complete Research Study and Industry Analysis of Cerus Corp (CERS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                        Last updated on

                                                                                                        REPORT YOU MIGHT BE INTERESTED

                                                                                                        Purchase this Report

                                                                                                        $500.00
                                                                                                        $1,000.00
                                                                                                        $1,500.00
                                                                                                        396.00
                                                                                                        792.00
                                                                                                        1,188.00
                                                                                                        462.00
                                                                                                        924.00
                                                                                                        1,386.00
                                                                                                        75,645.00
                                                                                                        151,290.00
                                                                                                        226,935.00
                                                                                                        41,685.00
                                                                                                        83,370.00
                                                                                                        125,055.00
                                                                                                        Credit card Logo

                                                                                                        Related Reports


                                                                                                        Reason to Buy

                                                                                                        Request for Sample of this report